Income Statement (FORTRESS/BIOTECH)

FORTRESS/BIOTECH NEWS

Fortress Biotech, Inc. (NASDAQ:FBIO) Stocks Bought via PFG Investments LLC By MarketBeat - 2 weeks ago

PFG Investments LLC boosted its holdings in Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) by 28.4% during the 1st quarter, Holdings Channel reports. The fund owned 45,259 shares of the biopharma… [+3999 chars]...

Read more
Fortress Biotech (NASDAQ:FBIO) Inventory Passes Above 200-Day Shifting Reasonable – Right here’s Why By MarketBeat - 3 weeks ago

Fortress Biotech, Inc. (NASDAQ:FBIO – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $1.78… [+3566 chars]...

Read more
Cambridge Funding Analysis Advisors Inc. Has $1.57 Million Stake in Fortress Biotech, Inc. (NASDAQ:FBIO) By MarketBeat - 2 weeks ago

Cambridge Investment Research Advisors Inc. grew its position in Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) by 8.7% in the 1st quarter, according to its most recent filing with the Securities… [+3870 chars]...

Read more
This founder has spent a decade development a multi-million-dollar spice corporation that is nearly worthwhile. She nonetheless doesn’t desire your challenge capital bucks—as a minimum no longer for now By Jessica - 2 weeks ago

I reached out to founder Sana Javeri Kadri earlier this week, because I needed some answers. Its summertime here in Arkansas, I just bought a new grill, and I have been putting Diaspora Co. spices on… [+6106 chars]...

Read more
Contrasting Checkpoint Therapeutics (NASDAQ:CKPT) and Palatin Applied sciences (NYSE:PTN) By MarketBeat - 1 month ago

Palatin Technologies (NYSE:PTN – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap manufacturing companies, but which is the better business? We will con… [+6011 chars]...

Read more
Adventure Scientific Company Publicizes Expanded Payer Protection for Emrosi™ By Journey - 3 days ago

Payer coverage for Emrosi now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to increase SC… [+10467 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA
231 1.1
0.48%
CVX
151.38 1.46
0.97%
CAT
418.07 5.19
1.26%
INTC
22.8 0.11
0.48%
MSFT
511.78 6.16
1.22%
DIS
122.21 2.39
1.99%
DOW
28.46 0.32
1.14%
CSCO
68.32 0.95
1.41%
GS
705.84 -2.98
-0.42%